SUSTOL® (GRANISETRON EXTENDED RELEASE) INJECTION COMMERCIAL MANUFACTURING SERVICES AGREEMENT – FINISHED FINAL DRUG PRODUCTCommercial Manufacturing Services Agreement • May 29th, 2015 • Heron Therapeutics, Inc. /De/ • Pharmaceutical preparations • New York
This Agreement between Lifecore Biomedical, LLC, a Minnesota (U.S.A.) entity with offices located at 3515 Lyman Boulevard, Chaska, Minnesota 55318 (“Lifecore”) and Heron Therapeutics, Inc., a Delaware corporation with offices located at 123 Saginaw Drive, Redwood City, California 94063 (“Heron”), is effective as of May 27, 2015 (“Effective Date”).
